Enhancing clinical trials with real-world data

Sujay Jadhav, CEO of Verana Health highlights how real-time real-world data dashboards are transforming the way life sciences ...

Adoption Of AI In Clinical Trials: At The Speed Of Trust

The adoption of AI in clinical trials holds the potential to revolutionize how therapies are discovered, but the pace of that ...
Applied Clinical Trials Online

The Use of Real-World Data and Evidence in Clinical Trials

Real-world data is increasingly used to optimize trial design, reduce recruitment burden, and support regulatory decisions, but adoption remains uneven due to challenges around data quality, ...
Seeking Alpha

Aridis Receives Agreement from the FDA on a Single Confirmatory Phase 3 Study of AR-301 and the Clinical Study Design

“We are particularly gratified to reach concurrence with the FDA on the overall study design, endpoints, and patient populations,” said Aridis CEO Vu Truong. “This provides a clear clinical and ...

Why Wearables Are The UX Upgrade That Clinical Trials Need

Clinical trials are losing participants. Patient-first design and decentralized models can help fix the dropout problem.
FiercePharma

How to Improve Diversity in Clinical Research, from Mass General Hospital

A common thread in your work has been connecting people to clinical trials. Was that the focus in founding the CARE Research Center? The impetus behind the CARE Research Center is probably not so ...
Seeking Alpha

Aridis Receives Agreement from the European Medicines Agency (EMA) on the Clinical Study Design and a Single Confirmatory Phase 3 Study of AR-301

LOS GATOS, Calif., July 17, 2023 (GLOBE NEWSWIRE) -- Aridis Pharmaceuticals, Inc. (ARDS) today announced positive feedback from the European Medicines Agency (EMA) on the Company’s proposed single ...